GILD - Gilead gains label extension for hepatitis B drug Vemlidy
2024-03-28 11:04:59 ET
More on Gilead Sciences
- Gilead Sciences Finally Starts Succeeding
- Gilead Sciences: Realizing Financial Projections Is Key
- Gilead Sciences, Inc. (GILD) Barclays 26th Annual Global Healthcare Conference (Transcript)
- Xilio stock jumps on Gilead Sciences license deal
- Gilead completes CymaBay acquisition but negative impact on 2024 EPS